603882 金域医学
交易中 03-17 10:42:58
资讯
新帖
简况
金域医学新注册《医检项目智慧定价系统（SPP）V2.38》项目的软件著作权
证券之星 · 02:13
金域医学新注册《医检项目智慧定价系统（SPP）V2.38》项目的软件著作权
金域医学新注册《金域集团资质证照管理平台V1.0》项目的软件著作权
证券之星 · 03-07
金域医学新注册《金域集团资质证照管理平台V1.0》项目的软件著作权
股市必读：金域医学（603882）3月3日收盘跌5.06%，主力净流出4103.7万元
证券之星 · 03-04
股市必读：金域医学（603882）3月3日收盘跌5.06%，主力净流出4103.7万元
每周股票复盘：金域医学（603882）梁耀铭质押950万股用于还债
证券之星 · 03-01
每周股票复盘：金域医学（603882）梁耀铭质押950万股用于还债
金域医学（603882）披露控股股东部分股份解除质押公告，2月26日股价上涨0.03%
证券之星 · 02-26
金域医学（603882）披露控股股东部分股份解除质押公告，2月26日股价上涨0.03%
金域医学新注册《金域实验室信息管理系统V1.0》等2个项目的软件著作权
证券之星 · 02-25
金域医学新注册《金域实验室信息管理系统V1.0》等2个项目的软件著作权
金域医学新注册《金域成本经营指标报表系统V1.0》项目的软件著作权
证券之星 · 02-13
金域医学新注册《金域成本经营指标报表系统V1.0》项目的软件著作权
金域医学新注册《金域集团域管家平台V1.0》等3个项目的软件著作权
证券之星 · 02-12
金域医学新注册《金域集团域管家平台V1.0》等3个项目的软件著作权
每周股票复盘：金域医学（603882）2025年预亏1.2亿至1.8亿
证券之星 · 02-01
每周股票复盘：金域医学（603882）2025年预亏1.2亿至1.8亿
金域医学新注册《金域集团质量管理缺陷成本管理系统（DCS）V14.1》等2个项目的软件著作权
证券之星 · 02-01
金域医学新注册《金域集团质量管理缺陷成本管理系统（DCS）V14.1》等2个项目的软件著作权
股市必读：金域医学（603882）预计2025年全年扣非后净利润亏损1.2亿元至1.8亿元
证券之星 · 01-28
股市必读：金域医学（603882）预计2025年全年扣非后净利润亏损1.2亿元至1.8亿元
金域医学(603882.SH)发预亏，预计2025年归母净亏损1.3亿元到1.9亿元
智通财经 · 01-27
金域医学(603882.SH)发预亏，预计2025年归母净亏损1.3亿元到1.9亿元
每周股票复盘：金域医学（603882）临时股东会通过利润分配预案
证券之星 · 01-25
每周股票复盘：金域医学（603882）临时股东会通过利润分配预案
金域医学新注册《HPV样本扫码定位管理系统V1.0》等2个项目的软件著作权
证券之星 · 01-24
金域医学新注册《HPV样本扫码定位管理系统V1.0》等2个项目的软件著作权
每周股票复盘：金域医学（603882）预计2025年净利润为负值
证券之星 · 01-18
每周股票复盘：金域医学（603882）预计2025年净利润为负值
金域医学拟派发2025年前三季度现金红利并修订公司章程
中金财经 · 01-14
金域医学拟派发2025年前三季度现金红利并修订公司章程
金域医学（603882）披露2025年年度业绩预告提示性公告，1月13日股价下跌0.95%
证券之星 · 01-13
金域医学（603882）披露2025年年度业绩预告提示性公告，1月13日股价下跌0.95%
金域医学(603882.SH)：预计2025年年度归属于上市公司股东的净利润为负值
智通财经 · 01-13
金域医学(603882.SH)：预计2025年年度归属于上市公司股东的净利润为负值
金域医学最新公告：公司生产经营正常无应披露而未披露的重大事项
证券之星 · 01-12
金域医学最新公告：公司生产经营正常无应披露而未披露的重大事项
1月12日金域医学（603882）龙虎榜数据：机构净卖出8769.08万元（3日），北向资金净卖出1.71亿元（3日）
证券之星 · 01-12
1月12日金域医学（603882）龙虎榜数据：机构净卖出8769.08万元（3日），北向资金净卖出1.71亿元（3日）
加载更多
公司概况
公司名称：
广州金域医学检验集团股份有限公司
所属行业：
卫生
上市日期：
2017-09-08
主营业务：
广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学检验及检验+AI技术。获得美国CAP、中国CNAS等国内外权威机构认证180项。
发行价格：
6.93
{"stockData":{"symbol":"603882","market":"SH","secType":"STK","nameCN":"金域医学","latestPrice":28.16,"timestamp":1773715378000,"preClose":28.03,"halted":0,"volume":1923071,"delay":0,"changeRate":0.0046,"floatShares":459999999,"shares":463000000,"eps":-1.1974,"marketStatus":"交易中","change":0.13,"latestTime":"03-17 10:42:58","open":28.06,"high":28.3,"low":28,"amount":54155200,"amplitude":0.0107,"askPrice":28.18,"askSize":1,"bidPrice":28.17,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-1.1974,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1773718200000},"marketStatusCode":2,"adr":0,"adjPreClose":28.03,"symbolType":"stock","openAndCloseTimeList":[[1773711000000,1773718200000],[1773723600000,1773730800000]],"highLimit":30.83,"lowLimit":25.23,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":463258275,"isCdr":false,"pbRate":1.9,"roa":"--","roe":"--","epsLYR":-0.82,"committee":0.274725,"marketValue":13045000000,"turnoverRate":0.0042,"status":0,"floatMarketCap":12957000000},"requestUrl":"/m/hq/s/603882","defaultTab":"news","newsList":[{"id":"2620493482","title":"金域医学新注册《医检项目智慧定价系统（SPP）V2.38》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2620493482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620493482?lang=zh_cn&edition=full","pubTime":"2026-03-17 02:13","pubTimestamp":1773684793,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《医检项目智慧定价系统V2.38》项目的软件著作权。今年以来金域医学新注册软件著作权21个，较去年同期减少了40%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.61亿元，同比减18.32%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息189条；此外企业还拥有行政许可57个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700001821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0042","603882","BK0284","SG9999001069.SGD"],"gpt_icon":0},{"id":"2617632344","title":"金域医学新注册《金域集团资质证照管理平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617632344?lang=zh_cn&edition=full","pubTime":"2026-03-07 01:55","pubTimestamp":1772819717,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《金域集团资质证照管理平台V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权20个，较去年同期减少了28.57%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.61亿元，同比减18.32%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息188条；此外企业还拥有行政许可57个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030700000228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","603882","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2616721320","title":"股市必读：金域医学（603882）3月3日收盘跌5.06%，主力净流出4103.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616721320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616721320?lang=zh_cn&edition=full","pubTime":"2026-03-04 01:36","pubTimestamp":1772559373,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，金域医学报收于28.7元，下跌5.06%，换手率2.05%，成交量9.42万手，成交额2.76亿元。来自交易信息汇总：当日主力资金净流出4103.7万元，占总成交额14.87%。交易信息汇总股价提醒3月3日金域医学收盘报28.7元，跌5.06%，当日成交942.08万元。该股已连续2日下跌。前10个交易日中，主力资金累计净流出5893.5万元，股价累计下跌9.72%；融资余额累计增加1415.51万元，融券余量累计减少500股。最近90天内，共有3家机构对该股给出买入评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","603882","SG9999001069.SGD","BK0042"],"gpt_icon":0},{"id":"2616845153","title":"每周股票复盘：金域医学（603882）梁耀铭质押950万股用于还债","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845153?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:58","pubTimestamp":1772305090,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，金域医学报收于31.14元，较上周的31.18元下跌0.13%。梁耀铭先生本次解除质押的股份尚无后续质押计划。截至公告日，梁耀铭及其一致行动人合计累计质押股份31,580,000股，占其持有公司股份总数的19.14%，占公司总股本的6.82%。广州金域医学检验集团股份有限公司控股股东、实际控制人梁耀铭先生本次质押股份9,500,000股，占其直接持有公司股份数的12.80%，占公司总股本的2.05%。质押融资资金用途为偿还质押债务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","SG9999001069.SGD","BK0284","BK0042","603882"],"gpt_icon":0},{"id":"2614247028","title":"金域医学（603882）披露控股股东部分股份解除质押公告，2月26日股价上涨0.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614247028","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614247028?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:35","pubTimestamp":1772116519,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，金域医学报收于30.86元，较前一交易日上涨0.03%，最新总市值为142.96亿元。近日，广州金域医学检验集团股份有限公司发布公告称，公司控股股东、实际控制人梁耀铭先生将其持有的9,500,000股公司股份办理了解除质押手续，占其所持股份的12.80%，占公司总股本的2.05%。截至公告日，梁耀铭及其一致行动人合计累计质押股份31,580,000股，占其持有公司股份总数的19.14%，占公司总股本的6.82%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","603882","SG9999001069.SGD","BK0284","BK0236"],"gpt_icon":0},{"id":"2614763741","title":"金域医学新注册《金域实验室信息管理系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2614763741","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614763741?lang=zh_cn&edition=full","pubTime":"2026-02-25 02:09","pubTimestamp":1771956553,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了2个项目的软件著作权，包括《金域实验室信息管理系统V1.0》、《自定义计算建议解释实验室管理系统V1.0》等。今年以来金域医学新注册软件著作权19个，较去年同期减少了9.52%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息186条；此外企业还拥有行政许可52个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500001090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","603882","BK0236","SG9999001069.SGD","BK0284"],"gpt_icon":0},{"id":"2611979467","title":"金域医学新注册《金域成本经营指标报表系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2611979467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611979467?lang=zh_cn&edition=full","pubTime":"2026-02-13 02:09","pubTimestamp":1770919754,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了《金域成本经营指标报表系统V1.0》项目的软件著作权。今年以来金域医学新注册软件著作权15个，较去年同期减少了28.57%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.61亿元，同比减18.32%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息176条；此外企业还拥有行政许可52个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021300000878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","SG9999001069.SGD","BK0284","603882","BK0236"],"gpt_icon":0},{"id":"2610495092","title":"金域医学新注册《金域集团域管家平台V1.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610495092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610495092?lang=zh_cn&edition=full","pubTime":"2026-02-12 02:01","pubTimestamp":1770832882,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了3个项目的软件著作权，包括《金域集团域管家平台V1.0》、《金域集团KDC资料系统V1.0》、《金域ANA实验室管理系统V1.0》等。今年以来金域医学新注册软件著作权10个，较去年同期减少了52.38%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息176条；此外企业还拥有行政许可52个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200001328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0284","SG9999001069.SGD","603882","BK0236"],"gpt_icon":0},{"id":"2608077880","title":"每周股票复盘：金域医学（603882）2025年预亏1.2亿至1.8亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077880","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077880?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:12","pubTimestamp":1769883130,"startTime":"0","endTime":"0","summary":"业绩披露要点金域医学发布业绩预告，预计2025年全年扣非后净利润亏损1.2亿元至1.8亿元。公司公告汇总广州金域医学检验集团股份有限公司预计2025年年度归属于上市公司股东的净利润为-13,000万元到-19,000万元，与上年同期相比同比减亏19,124.11万元到25,124.11万元。广州金域医学检验集团股份有限公司2025年前三季度权益分派实施公告，每股派发现金红利0.88元（含税），股权登记日为2026年2月4日，除权（息）日和现金红利发放日均为2026年2月5日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0236","BK0042","603882","SG9999001069.SGD"],"gpt_icon":0},{"id":"2608607207","title":"金域医学新注册《金域集团质量管理缺陷成本管理系统（DCS）V14.1》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2608607207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608607207?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:05","pubTimestamp":1769882719,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了2个项目的软件著作权，包括《金域集团质量管理缺陷成本管理系统V14.1》、《基于NGS的人类HLA-LOSS分析系统V1.0》等。今年以来金域医学新注册软件著作权7个，较去年同期减少了56.25%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息174条；此外企业还拥有行政许可52个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","SG9999001069.SGD","BK0284","BK0236","603882"],"gpt_icon":0},{"id":"2606893731","title":"股市必读：金域医学（603882）预计2025年全年扣非后净利润亏损1.2亿元至1.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606893731","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606893731?lang=zh_cn&edition=full","pubTime":"2026-01-28 01:06","pubTimestamp":1769533573,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，金域医学报收于32.99元，上涨0.21%，换手率2.56%，成交量11.79万手，成交额3.87亿元。业绩披露要点金域医学发布业绩预告，预计2025年全年扣非后净利润亏损1.2亿元至1.8亿元。公司公告汇总广州金域医学检验集团股份有限公司预计2025年年度归属于上市公司股东的净利润为-13,000万元到-19,000万元，与上年同期相比同比减亏19,124.11万元到25,124.11万元。扣除非经常性损益后的净利润预计为-12,000万元到-18,000万元。本次业绩未经审计，最终数据以2025年年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800000791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"gpt_icon":0},{"id":"2606789608","title":"金域医学(603882.SH)发预亏，预计2025年归母净亏损1.3亿元到1.9亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606789608","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606789608?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:01","pubTimestamp":1769515278,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金域医学(603882.SH)发布公告，公司预计2025年年度实现归属于上市公司股东的净利润为-1.3亿元到-1.9亿元，与上年同期相比，将同比减亏19,124.11万元到25,124.11万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","603882","SG9999001069.SGD","BK0284","BK0236"],"gpt_icon":0},{"id":"2606723477","title":"每周股票复盘：金域医学（603882）临时股东会通过利润分配预案","url":"https://stock-news.laohu8.com/highlight/detail?id=2606723477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606723477?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:13","pubTimestamp":1769278391,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，金域医学报收于33.53元，较上周的32.6元上涨2.85%。公司公告汇总北京市中伦律师事务所出具法律意见书，确认广州金域医学检验集团股份有限公司2026年第一次临时股东会的召集、召开程序、出席人员及召集人资格、表决程序和表决结果均符合相关法律法规及公司章程规定。本次股东会审议通过了2025年前三季度利润分配预案及变更经营范围并修订公司章程的议案。现场与网络投票合计447名股东参会，代表股份占公司总股本的42.6932%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","SG9999001069.SGD","BK0042","603882"],"gpt_icon":0},{"id":"2605407227","title":"金域医学新注册《HPV样本扫码定位管理系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2605407227","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605407227?lang=zh_cn&edition=full","pubTime":"2026-01-24 02:34","pubTimestamp":1769193261,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金域医学新注册了2个项目的软件著作权，包括《HPV样本扫码定位管理系统V1.0》、《金域集团质量管理虚拟实验室RBE系统V19.0》等。今年以来金域医学新注册软件著作权5个，较去年同期减少了66.67%。通过天眼查大数据分析，广州金域医学检验集团股份有限公司共对外投资了58家企业，参与招投标项目29次；财产线索方面有商标信息766条，专利信息220条，著作权信息174条；此外企业还拥有行政许可46个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400001207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0284","BK0042","603882","SG9999001069.SGD"],"gpt_icon":0},{"id":"2604928938","title":"每周股票复盘：金域医学（603882）预计2025年净利润为负值","url":"https://stock-news.laohu8.com/highlight/detail?id=2604928938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604928938?lang=zh_cn&edition=full","pubTime":"2026-01-18 01:29","pubTimestamp":1768670947,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，金域医学报收于32.6元，较上周的33.66元下跌3.15%。业绩披露要点业绩预告金域医学发布业绩预告，预计2025年全年归属净利润为负值，年度经营业绩将出现亏损。最终数据以正式披露的2025年年度报告为准。广州金域医学检验集团股份有限公司关于2025年年度业绩预告的提示性公告经财务部门初步测算，预计2025年年度归属于上市公司股东的净利润为负值，主要因应收账款回款周期延长引发较大信用减值损失。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603882"],"gpt_icon":0},{"id":"2603609659","title":"金域医学拟派发2025年前三季度现金红利并修订公司章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2603609659","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603609659?lang=zh_cn&edition=full","pubTime":"2026-01-14 08:04","pubTimestamp":1768349057,"startTime":"0","endTime":"0","summary":"中访网数据 广州金域医学检验集团股份有限公司于2026年1月21日召开2026年第一次临时股东会，审议通过两项重要议案。核心决策包括：公司拟实施2025年前三季度利润分配，以总股本463,258,275股为基数，向全体股东每10股派发现金红利8.80元(含税)，合计拟派发现金红利约4.08亿元。为此，公司同步修订了《公司章程》中相应的经营范围条款。上述利润分配方案及章程修订尚需提交股东会审议，经营范围的最终变更以工商部门核准为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260114/31939254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["SG9999001069.SGD","BK0236","603882","BK0042","BK0284"],"gpt_icon":0},{"id":"2603638153","title":"金域医学（603882）披露2025年年度业绩预告提示性公告，1月13日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603638153","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603638153?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:36","pubTimestamp":1768314973,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，金域医学报收于36.68元，较前一交易日下跌0.95%，最新总市值为169.92亿元。该股当日开盘39.13元，最高40.68元，最低36.3元，成交额达21.67亿元，换手率为12.34%。公司近日发布公告称，经财务部门初步测算，预计2025年年度归属于上市公司股东的净利润为负值，公司2025年年度经营业绩将出现亏损，主要原因为部分应收账款回款周期延长，导致产生较大的信用减值损失。公司将加快推进财务核算工作，尽快披露2025年年度业绩预告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300042505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","603882","BK0284","BK0042","BK0236"],"gpt_icon":0},{"id":"2603078635","title":"金域医学(603882.SH)：预计2025年年度归属于上市公司股东的净利润为负值","url":"https://stock-news.laohu8.com/highlight/detail?id=2603078635","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603078635?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:43","pubTimestamp":1768297416,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金域医学(603882.SH)发布公告，经公司财务部门初步测算，预计2025年年度归属于上市公司股东的净利润为负值，公司2025年年度经营业绩将出现亏损，主要原因是由于部分应收账款回款周期延长，导致产生较大的信用减值损失。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"金域医学(603882.SH)：预计2025年年度归属于上市公司股东的净利润为负值","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603882"],"gpt_icon":0},{"id":"2602513667","title":"金域医学最新公告：公司生产经营正常无应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2602513667","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602513667?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:51","pubTimestamp":1768211500,"startTime":"0","endTime":"0","summary":"金域医学(603882.SH)公告称，公司股票交易连续三个交易日内收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动情形。经自查，公司目前生产经营情况正常，市场环境或行业政策没有发生重大调整，除已在指定媒体公开披露的信息外，确认不存在应披露而未披露的重大事项或重要信息。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200025366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","603882","SG9999001069.SGD","BK0236","BK0042"],"gpt_icon":0},{"id":"2602394513","title":"1月12日金域医学（603882）龙虎榜数据：机构净卖出8769.08万元（3日），北向资金净卖出1.71亿元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2602394513","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602394513?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:48","pubTimestamp":1768211331,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年1月12日公布的交易公开信息显示，金域医学因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月12日收盘，金域医学报收于37.03元，上涨10.01%，已连续涨停2天，换手率10.26%，成交量47.2万手，成交额17.21亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出8769.08万元，北向资金合计净卖出1.71亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200025024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","603882","BK0236","SG9999001069.SGD","BK0284"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773715386656,"stockEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.101},{"period":"3month","weight":0.0521},{"period":"6month","weight":-0.0855},{"period":"1year","weight":-0.2019},{"period":"ytd","weight":0.0161}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.068},{"period":"6month","weight":0.0538},{"period":"1year","weight":0.1945},{"period":"ytd","weight":0.0292}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州金域医学检验集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"41671人(较上一季度减少1.60%)","perCapita":"11042股","listingDate":"2017-09-08","address":"广东省广州市海珠区国际生物岛螺旋三路10号","registeredCapital":"46325万元","survey":" 广州金域医学检验集团股份有限公司的主营业务是第三方医学检验及病理诊断业务。公司的主要产品是医学检验及检验+AI技术。获得美国CAP、中国CNAS等国内外权威机构认证180项。","listedPrice":6.93},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金域医学,603882,金域医学股票,金域医学股票老虎,金域医学股票老虎国际,金域医学行情,金域医学股票行情,金域医学股价,金域医学股市,金域医学股票价格,金域医学股票交易,金域医学股票购买,金域医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金域医学(603882)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金域医学(603882)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}